ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-01897
製品名称
PRSS3 Protein, Human, Recombinant (His)
タンパク質名
PRSS3
Species
Human
HOST
HEK293 Cells
50μg: -
お問い合わせ

Overview

Synonyms TRY3, RP11-176F3.3, T9, MTG, PRSS4, TRY4, protease, serine 3
Characteristics Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2. The specific activity is >4,000 pmoles/min/μg. (Activation description: The proenzyme needs to be activated by enteropeptidase for an activated form)
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 98.60%
Description Trypsin-3, also known as Trypsin III, brain trypsinogen, Serine protease 3 and PRSS3, is a secreted protein that belongs to the peptidase S1 family. Trypsin-3 / PRSS3 is expressed is in pancreas and brain. It contains one peptidase S1 domain. Trypsin-3 / PRSS3 can degrade intrapancreatic trypsin inhibitors that protect against CP. Genetic variants that cause higher mesotrypsin activity might increase the risk for chronic pancreatitis (CP). A sustained imbalance of pancreatic proteases and their inhibitors seems to be important for the development of CP. The trypsin inhibitor-degrading activity qualified PRSS3 as a candidate for a novel CP susceptibility gene. Trypsin-3 / PRSS3 has been implicated as a putative tumor suppressor gene due to its loss of expression, which is correlated with promoter hypermethylation, in esophageal squamous cell carcinoma and gastric adenocarcinoma.
Reference Rowen, L. et al., 2005, Mol Biol Evol. 22?(8):1712-20.,Venter JC. et al., 2001, Science 291:1304-51.,Marsit,CJ. et al., 2005,?Mol Carcinog?44?(2):146-50.,Rosendahl, J. et al., 2010, Pancreatology. 10?(2-3):243-9
URL https://www.targetmol.com/recombinant-protein/prss3_protein_human_recombinant_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム